Plant-derived therapeutics for the treatment of metabolic syndrome

B. L. Graf, I. Raskin, W. T. Cefalu, D. M. Ribnicky

Research output: Contribution to journalReview articlepeer-review

53 Scopus citations

Abstract

Metabolic syndrome is defined as a set of coexisting metabolic disorders that increase an individual's likelihood of developing type 2 diabetes, cardiovascular disease and stroke. Medicinal plants, some of which have been used for thousands of years, serve as an excellent source of bioactive compounds for the treatment of metabolic syndrome because they contain a wide range of phytochemicals with diverse metabolic effects. In order for botanicals to be effectively used against metabolic syndrome, however, botanical preparations must be characterized and standardized through the identification of their active compounds and respective modes of action, followed by validation in controlled clinical trials with clearly defined endpoints. This review assesses examples of commonly known and partially characterized botanicals to describe specific considerations for the phytochemical, preclinical and clinical characterization of botanicals associated with metabolic syndrome.

Original languageEnglish (US)
Pages (from-to)1107-1115
Number of pages9
JournalCurrent Opinion in Investigational Drugs
Volume11
Issue number10
StatePublished - Oct 2010

ASJC Scopus subject areas

  • Pharmacology
  • Drug Discovery

Keywords

  • Botanical
  • cardiovascular disease
  • diabetes
  • hypertension
  • insulin resistance
  • obesity
  • phytochemical

Fingerprint

Dive into the research topics of 'Plant-derived therapeutics for the treatment of metabolic syndrome'. Together they form a unique fingerprint.

Cite this